Showing 111 of 111on this page. Filters & sort apply to loaded results; URL updates for sharing.111 of 111 on this page
Liquid biopsy vs. Signatera ctDNA cancer monitoring test
ctDNA Testing for Skin Cancer – Signatera
Signatera – Circulating Tumor DNA Blood Test | Natera
Natera's Signatera Test Shows Survival Benefit in Bladder Cancer Trial ...
Colon Cancer Recurrence Blood Test – Signatera
Liquid Biopsy vs. Signatera ctDNA Monitoring Test | Natera
Signatera | Unilabs
Breast Cancer Recurrence Screening Blood Test – Signatera
Gastrointestinal Cancer Recurrence Blood Test – Signatera
ctDNA Testing for Lung Cancer – Signatera
Signatera – LifeLabs Genetics
Natera Signatera ctDNA: Early Detection of Testicular Cancer Relapse — TCAF
Skin Cancer Recurrence Blood Test – Signatera
Ovarian, Cervical, & Endometrial Cancer Recurrence Test – Signatera
When will cancer return? Personalized Signatera blood test can find ...
Signatera Genome | Natera Oncology
Signatera in Lymphoma | Natera
Signatera Test for Circulating Tumor DNA?
Signatera Genome | Natera
Signatera for Patients | Natera
Leveraging Signatera Residual Disease Test (MRD) to Support More ...
Signatera Recurrence and Treatment Monitoring for Ovarian Cancer ...
ctDNA Testing for Ovarian & Gynecologic Cancers – Signatera
Test Signatera - AMS Laborator Genetic
ctDNA Testing for Colon Cancer – Signatera
Lung Cancer Recurrence Screening Blood Test – Signatera
Signatera Clinicians | Natera
Natera's Signatera Test Detects Uterine Cancer Recurrence with 100% ...
Signatera
Exhibit 99.2
A Stage 4 Colorectal Cancer Patient Shares His Chemo Experience
Signatera™ ctDNA Blood Test from Alliance Trial Guides Use of Anti ...
Blog
Signatera: Transforming the management of NSCLC with personalized ctDNA ...
LifeLabs launches Signatera, offering Canadians an innovative and ...
Important Links
Genetic Cancer Test Granted FDA Breakthrough Device Designation ...
New Publication Validates Performance of Natera's Signatera™ MRD Test ...
Signatera™: A Personalized Test for Molecular Residual Disease ...
Colorectal Cancer Fighters & Survivors | March of 2025, at 39 years old ...
Natera, Inc. (NASDAQ:NTRA) Q1 2026 Earnings Call Transcript - Insider ...
